Abeona Therapeutics Inc.
ABEO
$5.40
-$0.01-0.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 6.17% | -47.39% | -34.44% | 37.94% | 21.89% |
| Gross Profit | 54.09% | 47.39% | 38.78% | -37.94% | -21.89% |
| SG&A Expenses | 144.62% | 201.59% | 98.35% | 37.39% | 31.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.93% | 56.52% | 29.83% | 37.66% | 26.22% |
| Operating Income | -37.42% | -56.52% | -27.59% | -37.66% | -26.22% |
| Income Before Tax | -122.48% | 32.74% | 1,578.98% | 61.91% | 43.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -120.17% | 82.95% | 1,369.52% | 61.91% | 43.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -120.17% | 82.95% | 1,369.52% | 61.91% | 43.99% |
| EBIT | -37.42% | -56.52% | -27.59% | -37.66% | -26.22% |
| EBITDA | -36.66% | -57.56% | -28.03% | -38.69% | -26.85% |
| EPS Basic | -94.08% | 84.89% | 1,019.39% | 79.10% | 70.44% |
| Normalized Basic EPS | -96.14% | 40.38% | -388.16% | 79.10% | 70.35% |
| EPS Diluted | -93.27% | 84.13% | 749.79% | 79.10% | 70.31% |
| Normalized Diluted EPS | -96.14% | 40.38% | -390.71% | 79.10% | 70.35% |
| Average Basic Shares Outstanding | 13.43% | 12.81% | 31.28% | 82.24% | 89.46% |
| Average Diluted Shares Outstanding | 13.43% | 12.81% | 30.09% | 82.24% | 89.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |